All News

Untangling The Web Of Hospital Regulation

Mar 15, 2019 / Robert Lord In War and Peace, Leo Tolstoy wrote, “Writing laws is easy, but governing is difficult.” It’s hard to imagine that in 1867, Tolstoy was writing about the regulatory burden on American hospitals, but he might as well have been. When it comes to governing health care, lawmakers and regulators can sometimes …

Centric Medical™ Announces First Clinical Cases with Saturn™ External Fixation System

March 15, 2019 HUNTLEY, Ill.–(BUSINESS WIRE)–Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the first clinical cases of SATURN External Fixation System. This System is comprised of various rings, struts, pins, bolts, and other fixation components intended …

SpineGuard Reports Solid Improvements in Its Full-Year 2018 Financial Results

March 14, 2019 PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Regulatory News: SpineGuard (FR0011464452 – ALSGD)(Paris:ALSGD), an innovative company that deploys its DSG® real time digital technology for surgical guidance intended to secure and streamline skeletal implant placement, reported today its full-year 2018 financial results as approved by the Board of Directors on March 13, 2019. € thousands …

AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft

CENTENNIAL, Colo., March 12, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that ProChondrix® CR now has a two-year shelf life based on the results of real-time testing. ProChondrix CR helps deliver the necessary components for articular cartilage restoration. This next generation of cartilage restoration therapy …

Medicare X could cost hospitals $800 billion over 10 years and disrupt health insurance market, study says

March 13, 2019 / Susan Morse, Senior Editor The proposed Medicare-X Choice Act could cost hospitals $800 billion over 10 years and significantly disrupt the health insurance exchanges, according to a study done on behalf of the American Hospital Association and the Federation of American Hospitals. The Medicare-X Choice Act would build on the Medicare framework to establish …

Kuros Biosciences Receives US Marketing Clearance for Intervertebral Body Fusion Device

SCHLIEREN (ZURICH), Switzerland, March 13, 2019 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has received clearance for the Kuros TLIF cage from the U.S. Food and Drug Administration (FDA). The TLIF cage has been developed for the use with KUR-113, Kuros’s advanced Fibrin-PTH product candidate for …

Stryker acquires OrthoSpace, Ltd.

Kalamazoo, Michigan, March 14, 2019 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, Israel, in an all cash transaction for an upfront payment of $110 million and future milestone payments of up to an additional $110 million. …

Exactech to Expand Hip Replacement System with New Acetabular Implant Featuring Vitamin E Technology

March 14, 2019 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a leading developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a new acetabular system, Alteon® Cup and XLE® Liner for hip replacement surgery. …

Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.

LONDON, March 12, 2019 /PRNewswire/ — Smith & Nephew plc (LSE: SN,NYSE: SNN), the global medical technology business, announces that it has agreed to acquire Osiris Therapeutics, Inc. (NASDAQ: OSIR), a fast growing company delivering regenerative medicine products, including skin, bone graft and articular cartilage substitutes, for $19.00 per share in cash, representing a total equity value of approximately $660 million. Namal Nawana, …

THINK Surgical and United Orthopedic Corporation Announce Collaboration to Deliver Enhanced Precision and Pursue Reproducible Outcomes in Total Knee Replacements

IRVINE, Calif., March 13, 2019 /PRNewswire/ — THINK Surgical, Inc. (THINK), an advanced robotic technology company and marketer of the first active robotic surgical system for orthopedic surgery, and United Orthopedic Corporation (UNITED), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced a collaboration aimed at enabling enhanced precision and providing a …

© 2019 MedDeviceJobs.com Powered by Careerleaf
v.3.1.4-1-gadb0b06